SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 161 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $39,000 | +875.0% | 1,000 | +233.3% | 0.03% | +1000.0% |
| Q1 2015 | $4,000 | -42.9% | 300 | -40.0% | 0.00% | -40.0% |
| Q4 2014 | $7,000 | -92.1% | 500 | -88.1% | 0.01% | -90.0% |
| Q3 2014 | $89,000 | +20.3% | 4,200 | +68.0% | 0.05% | +22.0% |
| Q2 2014 | $74,000 | +208.3% | 2,500 | +150.0% | 0.04% | +156.2% |
| Q1 2014 | $24,000 | -22.6% | 1,000 | -33.3% | 0.02% | -11.1% |
| Q4 2013 | $31,000 | -34.0% | 1,500 | +50.0% | 0.02% | -35.7% |
| Q3 2013 | $47,000 | -17.5% | 1,000 | -33.3% | 0.03% | -30.0% |
| Q2 2013 | $57,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |